A comparison of lens parameters in patients with various subtypes of primary angle-closure disease and the normal population: A prospective study.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
08 2022
Historique:
entrez: 3 8 2022
pubmed: 4 8 2022
medline: 5 8 2022
Statut: ppublish

Résumé

To assess the role of lens parameters in the detection and progression of primary angle-closure disease (PACD) by combining A-scan and A-scan optical coherence tomography (AS-OCT) parameters. A cross-sectional study was conducted in a tertiary health-care center in eastern India. A total of 91 study subjects including cases and controls were included in the study. The parameters studied were lens thickness (LT), lens axial factor (LAF), relative lens position (RLP), and lens vault (LV). Anterior chamber depth (ACD) and axial length (AL) were also analyzed using A-scan. The LT was significantly more in all subtypes of PACD (from 4.24 ± 0.84 to 5.02 ± 0.18 mm) than in controls (4.04 ± 0.46 mm; P < 0.01). Similarly, LAF was significantly less among all subtypes of PACD compared to controls (P < 0.001). The RLP, calculated using the formula (ACD + 0.5 LT)/AL × 10, showed no significant difference (P > 0.05) between various study groups. The LV in acute angle-closure glaucoma (AcCG) patients was significantly higher compared to the control population (P < 0.01). Ocular parameters like ACD decreased, whereas LT and LAF increased from normal through primary angle closure (PAC) to primary angle-closure glaucoma (PACG). Logistic regression analysis found a significant association between a decrease in ACD and an increased risk of PACG (P-value was 0.0001) and an increase in LT and LAF with increased risk of PACG (P = 0.040 and P = 0.006, respectively). Inclusion of lens parameter assessment in the workup of a patient with PACD helps in detection and close monitoring of the progression from suspected to disease state.

Identifiants

pubmed: 35918938
pii: IndianJOphthalmol_2022_70_8_2889_352861
doi: 10.4103/ijo.IJO_3007_21
pmc: PMC9672764
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2889-2894

Déclaration de conflit d'intérêts

None

Références

Clin Exp Ophthalmol. 2012 Aug;40(6):550-6
pubmed: 22171546
Am J Ophthalmol. 1997 Jul;124(1):53-60
pubmed: 9222233
Ophthalmology. 2011 Mar;118(3):474-9
pubmed: 21035864
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):776-83
pubmed: 14985290
Br J Ophthalmol. 2003 Apr;87(4):399-402
pubmed: 12642298
Clin Exp Ophthalmol. 2000 Aug;28(4):253-8
pubmed: 11021552
Arch Ophthalmol. 2008 May;126(5):686-91
pubmed: 18474780
Eye (Lond). 2009 Apr;23(4):933-9
pubmed: 18425069
J Ophthalmic Vis Res. 2013 Jan;8(1):17-24
pubmed: 23825708
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
Invest Ophthalmol Vis Sci. 2001 Jan;42(1):73-80
pubmed: 11133850
Int J Ophthalmol. 2017 Aug 18;10(8):1246-1250
pubmed: 28861350
Arch Ophthalmol. 2003 May;121(5):633-42
pubmed: 12742840
J Glaucoma. 2006 Jun;15(3):260-3
pubmed: 16778651
Acta Ophthalmol Scand. 1996 Apr;74(2):113-9
pubmed: 8739673
Arch Ophthalmol. 2004 Sep;122(9):1270-5
pubmed: 15364705
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Apr;39(4):333-7
pubmed: 24820267
Indian J Ophthalmol. 2011 Jan;59 Suppl:S76-81
pubmed: 21150038
Br J Ophthalmol. 1970 Feb;54(2):117-21
pubmed: 5441779
Arch Ophthalmol. 2005 Apr;123(4):527-32
pubmed: 15824227
Am J Ophthalmol. 2013 Apr;155(4):664-673, 673.e1
pubmed: 23246271
Indian J Ophthalmol. 1993 Jul;41(2):71-3
pubmed: 8262605
Eye (Lond). 2008 Apr;22(4):521-7
pubmed: 17304260
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
J Glaucoma. 2000 Jun;9(3):208-13
pubmed: 10877370
Acta Ophthalmol (Copenh). 1975 Mar;53(1):89-104
pubmed: 1172916
Optom Vis Sci. 2011 Jan;88(1):150-4
pubmed: 21150676
Br J Ophthalmol. 2018 Mar;102(3):329-337
pubmed: 28774936
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7611-7
pubmed: 26624492
Ophthalmology. 2003 Feb;110(2):376-82
pubmed: 12578784
J Glaucoma. 2003 Apr;12(2):167-80
pubmed: 12671473
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2593-9
pubmed: 27163773
Br J Ophthalmol. 1970 Mar;54(3):161-9
pubmed: 5428641
Arq Bras Oftalmol. 2011 Mar-Apr;74(2):83-4
pubmed: 21779659

Auteurs

Keya Chakrabarti (K)

Institute of Medical Science and SUM Hospital, Kalinga Nagar, Ghatikia, Bhubaneswar, Odisha, India.

Swati Samant (S)

Institute of Medical Science and SUM Hospital, Kalinga Nagar, Ghatikia, Bhubaneswar, Odisha, India.

Ramesh Mohapatra (R)

Institute of Medical Science and SUM Hospital, Kalinga Nagar, Ghatikia, Bhubaneswar, Odisha, India.

Suchismita Mishra (S)

Institute of Medical Science and SUM Hospital, Kalinga Nagar, Ghatikia, Bhubaneswar, Odisha, India.

Suprava Das (S)

Institute of Medical Science and SUM Hospital, Kalinga Nagar, Ghatikia, Bhubaneswar, Odisha, India.

Meena Chakrabarti (M)

Chakrabarti Eye Care Centre, Trivandrum, Kerala, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH